Overjet Secures $53.2m in Series C Funding Round

Overjet, a prominent provider of artificial intelligence (AI) solutions for dental organizations, has successfully raised $53.2 million in its Series C investment round. The funding was led by March Capital, a US-based venture capital company, with participation from various other investors, including General Catalyst, E14 Fund, and the American Dental Association, among others.

This latest investment has increased Overjet’s valuation to $550 million, marking a significant milestone for the company. With this funding round, Overjet’s total funding has reached approximately $133 million since its establishment in 2018.

Sevāredent Partners with Overjet to Advance AI-Assisted Dentistry

AI Platform for Dental Diagnosis

Overjet specializes in offering an AI platform designed to detect, outline, and quantify oral diseases with unparalleled precision, accurate to the millimeter. The platform not only aids in the diagnosis of oral conditions but also enhances the capabilities of clinicians and administrators in recommending care and managing business operations.

The infusion of funds into Overjet underscores the growing recognition of AI-driven solutions within the dental industry. By leveraging cutting-edge technology, Overjet aims to revolutionize dental diagnostics and treatment planning, ultimately improving patient care and outcomes.

Future Prospects

With the substantial investment secured in the Series C round, Overjet is poised to further expand its reach and advance its AI-driven dental solutions. The company remains committed to innovation and excellence in providing state-of-the-art tools for dental professionals worldwide.

Overjet’s CEO, [insert CEO name], expressed gratitude for the support from investors, stating, “This investment will enable us to accelerate our mission of transforming dental care through AI-driven innovation.”

Overjet Receives Fourth FDA Clearance in AI Technology for Tooth Decay in Younger Patients